| Primary |
| Surgery |
35.1% |
| Ophthalmological Examination |
22.1% |
| Product Used For Unknown Indication |
11.7% |
| Mydriasis |
5.8% |
| Drug Use For Unknown Indication |
5.2% |
| Hypertension |
2.6% |
| Diagnostic Procedure |
1.9% |
| Eye Disorder |
1.9% |
| Investigation |
1.9% |
| Wheezing |
1.9% |
| Dyspnoea |
1.3% |
| Open Angle Glaucoma |
1.3% |
| Pain |
1.3% |
| Pupil Dilation Procedure |
1.3% |
| Retinopathy |
1.3% |
| Blood Cholesterol Increased |
0.6% |
| Cataract |
0.6% |
| Fundoscopy |
0.6% |
| Glaucoma |
0.6% |
| Hypersensitivity |
0.6% |
|
| Corneal Disorder |
40.0% |
| Drug Effect Prolonged |
7.7% |
| Drug Ineffective |
4.6% |
| Medication Error |
4.6% |
| Syncope |
4.6% |
| Vision Blurred |
4.6% |
| Angle Closure Glaucoma |
3.1% |
| Blepharospasm |
3.1% |
| Dysarthria |
3.1% |
| Eye Irritation |
3.1% |
| Eye Pain |
3.1% |
| Hypersensitivity |
3.1% |
| Malaise |
3.1% |
| Viith Nerve Paralysis |
3.1% |
| Adverse Drug Reaction |
1.5% |
| Anaphylactic Reaction |
1.5% |
| Anaphylactic Shock |
1.5% |
| Chest Pain |
1.5% |
| Conjunctival Haemorrhage |
1.5% |
| Convulsion |
1.5% |
|
| Secondary |
| Cataract Operation |
33.6% |
| Ophthalmological Examination |
18.7% |
| Premedication |
11.2% |
| Age-related Macular Degeneration |
5.6% |
| Local Anaesthesia |
5.6% |
| Anaesthesia |
4.7% |
| Eye Irrigation |
3.7% |
| Hypertension |
2.8% |
| Mydriasis |
2.8% |
| Wheezing |
1.9% |
| Anxiety |
0.9% |
| Cataract |
0.9% |
| Coeliac Disease |
0.9% |
| Conjunctivitis Allergic |
0.9% |
| Corrective Lens User |
0.9% |
| Diagnostic Procedure |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Eye Numbness |
0.9% |
| Glaucoma |
0.9% |
| Hormone Replacement Therapy |
0.9% |
|
| Inflammation |
40.0% |
| Medication Error |
12.7% |
| Visual Acuity Reduced |
7.3% |
| Vitritis |
5.5% |
| Palpitations |
3.6% |
| Syncope |
3.6% |
| Vision Blurred |
3.6% |
| Circumstance Or Information Capable Of Leading To Medication Error |
1.8% |
| Corneal Opacity |
1.8% |
| Corneal Staining |
1.8% |
| Drug Ineffective |
1.8% |
| Hypertension |
1.8% |
| Iris Disorder |
1.8% |
| Ocular Hyperaemia |
1.8% |
| Post Procedural Complication |
1.8% |
| Psychotic Disorder |
1.8% |
| Pulmonary Oedema |
1.8% |
| Renal Failure Acute |
1.8% |
| Toxic Skin Eruption |
1.8% |
| Unresponsive To Stimuli |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.7% |
| Drug Use For Unknown Indication |
16.1% |
| Uveitis |
7.2% |
| Hiv Infection |
5.7% |
| Retinal Detachment |
4.7% |
| Type 1 Diabetes Mellitus |
4.7% |
| Cataract |
4.2% |
| Cytomegalovirus Chorioretinitis |
4.2% |
| Mydriasis |
4.2% |
| Prophylaxis |
3.8% |
| Insomnia |
3.2% |
| Rhabdomyosarcoma |
3.2% |
| Macular Degeneration |
2.7% |
| Behcet's Syndrome |
2.5% |
| Diabetes Mellitus |
2.3% |
| Depressed Mood |
2.1% |
| Hypertension |
2.1% |
| Intraocular Lens Implant |
2.1% |
| Preoperative Care |
2.1% |
| Schizophrenia |
2.1% |
|
| Vitritis |
14.0% |
| Uveitis |
8.1% |
| White Blood Cell Count Decreased |
7.0% |
| Angina Unstable |
5.8% |
| Foetal Distress Syndrome |
5.8% |
| Visual Acuity Reduced |
5.8% |
| Cytolytic Hepatitis |
4.7% |
| Floppy Iris Syndrome |
4.7% |
| Gastroduodenal Ulcer |
4.7% |
| Hypotension |
4.7% |
| Interstitial Lung Disease |
4.7% |
| Procedural Complication |
4.7% |
| Arthralgia |
3.5% |
| Corneal Disorder |
3.5% |
| Intestinal Obstruction |
3.5% |
| Miosis |
3.5% |
| Platelet Count Decreased |
3.5% |
| Presyncope |
3.5% |
| Corneal Oedema |
2.3% |
| Corneal Opacity |
2.3% |
|
